Nanosonics chief Michael Kavanagh wants to build Australia’s next medical device success story, replicating the success of his old employer, bionic ear maker Cochlear. Photo: Louie DouvisAfter a disappointing year for local biotechnology stocks, in which a number of high profile companies faltered on the back of poor clinical results or internal blunders, investors are scouring the sector for the […]
View gallery.The graphs below were produced by Capital Market Labs.A critical factor in assessing pharmaceutical and biotech companies is the quality of their drug pipelines. This is especially true as investors begin to look at the smaller companies in the space; the smaller the company, the more an investment is simply a bet on that particular pipeline.So, let’s take a look […]
On July 15th 2014, The Federal Reserve uttered the following warning to exuberant equity investors, “Valuation metrics in some sectors do appear substantially stretched — particularly those for smaller firms in the social-media and biotechnology industries.” 5 months later, Yellen Capital LP is half right…As Bloomberg reports,
Social-media shares declined after the report, as shown above, which tracks the performance of […]
Markets ended modestly higher on Wednesday’s abbreviated trading session banking on initial claims dropping to a seven-week low and gains in biotechs. The Dow hit a record high for the 37th session and Nasdaq also ended in the green. However, the S&P 500 erased its initial gains and a late selloff dragged the benchmark into the red.For a look at […]
Biotech stocks to buy in 2015: Biotech was one of the most profitable sectors this year. Through Dec. 18, the S&P 500 Biotechnology Index is up 43.6% in 2014, and the Nasdaq Biotechnology Index is up 36.9%.Those gains are three to six times as big as the broader markets’. In 2014 through Dec. 18, the Dow Jones Industrial Average is […]
Dividend paying stocks are a staple in market-beating investment portfolios, but dividend investors don’t have very many options when it comes to investing in the biotechnology sector. Out of the largest biotechnology stocks, only Amgen has made the decision to reward investors with dividend payments.That’s likely frustrating to dividend investors. After all, biotech stocks like Gilead Sciences generate billions of […]
It was an impressive turnaround on Tuesday for the stock market as, after Monday’s drop, the short-term momentum appeared to be turning negative. Of course, to keep the positive “Mo” going, we need to see further gains Wednesday. A drop back below Monday’s lows will turn the focus back on the downside.The S&P futures are flat in early trading and […]
The biotech industry has been absolutely soaring over the past two years, fueled by a rise in drug approvals, an merger-and-acquisition frenzy, and widespread reorganizations that have helped to mitigate the impact of the so-called “patent cliff.” Driving this point home, the closely watched iShares Nasdaq Biotechnology Index has appreciated a princely 162% since 2012:As earnings across the industry are […]
Why Has Biogen (BIIB) Stock Been Trading Down?
Biogen stock has been falling due to patent issues and negative sentiments regarding the death of a patient who had been using Tecfidera. However, the company’s pipeline drugs show potential
Published: November 21, 2014 at 2:19 pm ESTBy: Hannah IshmaelPage 1 of 2
Click Ticker to See live coverageBIIB
FWP
NVS
Biogen Idec Inc (NASDAQ:BIIB) stock has been […]
Biotech stocks surged nicely Tuesday with the iShares Biotechnology ETF rallying more than 2 percent.For the most part, biotech stocks have performed very well over the last month and even the last year.That performance can be seen quite well with names such as Gilead Sciences, Illumina and Vertex Pharmaceuticals all having hit new highs within the last 30 days.However, not […]
